<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arteriopathy</z:e> with subcortical <z:mpath ids='MPATH_124'>infarcts</z:mpath> and <z:hpo ids='HP_0002352'>leukoencephalopathy</z:hpo> (CADASIL) is an inherited cerebrovascular disease characterized by brain <z:mpath ids='MPATH_124'>infarcts</z:mpath>, <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> and <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The disease is caused by at least 91 missense mutations, four deletions and one splice site mutation in the NOTCH3 gene, which maps to 19p13.1 </plain></SENT>
<SENT sid="2" pm="."><plain>In 18 out of the 21 Finnish CADASIL families so far identified, the causative mutation is an arginine to cysteine substitution in position 133 (R133C) </plain></SENT>
<SENT sid="3" pm="."><plain>Most of the families carrying this mutation originate from the western coast of Finland, thus suggesting a <z:e sem="disease" ids="C0263541" disease_type="Disease or Syndrome" abbrv="">founder</z:e> effect </plain></SENT>
<SENT sid="4" pm="."><plain>No previous reports of a <z:e sem="disease" ids="C0263541" disease_type="Disease or Syndrome" abbrv="">founder</z:e> effect in CADASIL have been published </plain></SENT>
<SENT sid="5" pm="."><plain>We haplotyped 60 patients from these 18 families for 10 microsatellite markers in order to determine whether the families descend from a common ancestor </plain></SENT>
<SENT sid="6" pm="."><plain>We found a similar haplotype linked to the mutation in <z:hpo ids='HP_0000001'>all</z:hpo> 18 pedigrees, which indicates a single common ancestor for <z:hpo ids='HP_0000001'>all</z:hpo> the Finnish R133C families </plain></SENT>
<SENT sid="7" pm="."><plain>The age analysis of the <z:e sem="disease" ids="C0263541" disease_type="Disease or Syndrome" abbrv="">founder</z:e> mutation places the introduction of the mutation in the late 1600s or early 1700s </plain></SENT>
</text></document>